OpenAI leads the pack in this week's biggest funding surprises

OpenAI raised $6.6 billion in its latest funding round, increasing its valuation to approximately $157 billion. Thrive Capital led the investment, with participation from Fidelity and SoftBank. OpenAI transitions to a for-profit benefit corporation, which allows co-founder Sam Altman to gain equity. The funding includes convertible notes, enabling investors to withdraw if structural changes are not met within a set timeframe. In the AI sector, Poolside announced a $500 million Series B round, resulting in a $3 billion valuation. Kailera Therapeutics secured $400 million in Series A financing to develop treatments for chronic weight management. Aktis Oncology raised $175 million in Series B funding for research on alpha radiopharmaceuticals for cancer treatment. Impulse Space obtained $150 million for developing orbital transfer vehicles. Nusano and Triveni Bio each raised $115 million for healthcare innovations, reflecting strong investment trends in biotech and medical technologies.Learn more on this news visit us at: https://greyjournal.net/ Hosted on Acast. See acast.com/privacy for more information.